ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dexlansoprazole Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14I8496
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dexlansoprazole Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dexlansoprazole Market Insights, Forecast to 2030

Code: QYRE-Auto-14I8496
Report
December 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Takeda
Cardinal Health
SUZHOU HOMESUN PHARMACEUTICAL
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong

Dexlansoprazole Market

Dexlansoprazole is a proton pump inhibitor that decreases the amount of acid produced in the stomach. Dexlansoprazole is used to treat heartburn caused by gastroesophageal reflux disease (GERD), and to heal erosive esophagitis (damage to the esophagus from stomach acid).
The global Dexlansoprazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Dexlansoprazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Dexlansoprazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Dexlansoprazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Dexlansoprazole include Takeda, Cardinal Health, Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical and Sailong, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Dexlansoprazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dexlansoprazole, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dexlansoprazole, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dexlansoprazole sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Dexlansoprazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Dexlansoprazole sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Dexlansoprazole Market Report

Report Metric Details
Report Name Dexlansoprazole Market
Segment by Type
  • 30 mg
  • 60 mg
Segment by Application
  • Gastroesophageal Reflux Disease
  • Heal Erosive Esophagitis
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical, Sailong
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Dexlansoprazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Dexlansoprazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dexlansoprazole sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dexlansoprazole Market report?

Ans: The main players in the Dexlansoprazole Market are Suzhou Homesun Pharmaceutical, Frontida, Zhendong Group, Ouya Pharmaceutical, Heron Pharmaceutical, Sailong

What are the Application segmentation covered in the Dexlansoprazole Market report?

Ans: The Applications covered in the Dexlansoprazole Market report are Gastroesophageal Reflux Disease, Heal Erosive Esophagitis

What are the Type segmentation covered in the Dexlansoprazole Market report?

Ans: The Types covered in the Dexlansoprazole Market report are 30 mg, 60 mg

Recommended Reports

PPI & Acid Drugs

Gastro & Esophagus

Digestive Diagnostics

1 Study Coverage
1.1 Dexlansoprazole Product Introduction
1.2 Market by Type
1.2.1 Global Dexlansoprazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 30 mg
1.2.3 60 mg
1.3 Market by Application
1.3.1 Global Dexlansoprazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Gastroesophageal Reflux Disease
1.3.3 Heal Erosive Esophagitis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dexlansoprazole Sales Estimates and Forecasts 2019-2030
2.2 Global Dexlansoprazole Revenue by Region
2.2.1 Global Dexlansoprazole Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Dexlansoprazole Revenue by Region (2019-2024)
2.2.3 Global Dexlansoprazole Revenue by Region (2025-2030)
2.2.4 Global Dexlansoprazole Revenue Market Share by Region (2019-2030)
2.3 Global Dexlansoprazole Sales Estimates and Forecasts 2019-2030
2.4 Global Dexlansoprazole Sales by Region
2.4.1 Global Dexlansoprazole Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Dexlansoprazole Sales by Region (2019-2024)
2.4.3 Global Dexlansoprazole Sales by Region (2025-2030)
2.4.4 Global Dexlansoprazole Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Dexlansoprazole Sales by Manufacturers
3.1.1 Global Dexlansoprazole Sales by Manufacturers (2019-2024)
3.1.2 Global Dexlansoprazole Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dexlansoprazole in 2023
3.2 Global Dexlansoprazole Revenue by Manufacturers
3.2.1 Global Dexlansoprazole Revenue by Manufacturers (2019-2024)
3.2.2 Global Dexlansoprazole Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Dexlansoprazole Revenue in 2023
3.3 Global Key Players of Dexlansoprazole, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Dexlansoprazole Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Dexlansoprazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Dexlansoprazole, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Dexlansoprazole, Product Offered and Application
3.8 Global Key Manufacturers of Dexlansoprazole, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dexlansoprazole Sales by Type
4.1.1 Global Dexlansoprazole Historical Sales by Type (2019-2024)
4.1.2 Global Dexlansoprazole Forecasted Sales by Type (2025-2030)
4.1.3 Global Dexlansoprazole Sales Market Share by Type (2019-2030)
4.2 Global Dexlansoprazole Revenue by Type
4.2.1 Global Dexlansoprazole Historical Revenue by Type (2019-2024)
4.2.2 Global Dexlansoprazole Forecasted Revenue by Type (2025-2030)
4.2.3 Global Dexlansoprazole Revenue Market Share by Type (2019-2030)
4.3 Global Dexlansoprazole Price by Type
4.3.1 Global Dexlansoprazole Price by Type (2019-2024)
4.3.2 Global Dexlansoprazole Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Dexlansoprazole Sales by Application
5.1.1 Global Dexlansoprazole Historical Sales by Application (2019-2024)
5.1.2 Global Dexlansoprazole Forecasted Sales by Application (2025-2030)
5.1.3 Global Dexlansoprazole Sales Market Share by Application (2019-2030)
5.2 Global Dexlansoprazole Revenue by Application
5.2.1 Global Dexlansoprazole Historical Revenue by Application (2019-2024)
5.2.2 Global Dexlansoprazole Forecasted Revenue by Application (2025-2030)
5.2.3 Global Dexlansoprazole Revenue Market Share by Application (2019-2030)
5.3 Global Dexlansoprazole Price by Application
5.3.1 Global Dexlansoprazole Price by Application (2019-2024)
5.3.2 Global Dexlansoprazole Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Dexlansoprazole Market Size by Type
6.1.1 US & Canada Dexlansoprazole Sales by Type (2019-2030)
6.1.2 US & Canada Dexlansoprazole Revenue by Type (2019-2030)
6.2 US & Canada Dexlansoprazole Market Size by Application
6.2.1 US & Canada Dexlansoprazole Sales by Application (2019-2030)
6.2.2 US & Canada Dexlansoprazole Revenue by Application (2019-2030)
6.3 US & Canada Dexlansoprazole Market Size by Country
6.3.1 US & Canada Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Dexlansoprazole Sales by Country (2019-2030)
6.3.3 US & Canada Dexlansoprazole Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Dexlansoprazole Market Size by Type
7.1.1 Europe Dexlansoprazole Sales by Type (2019-2030)
7.1.2 Europe Dexlansoprazole Revenue by Type (2019-2030)
7.2 Europe Dexlansoprazole Market Size by Application
7.2.1 Europe Dexlansoprazole Sales by Application (2019-2030)
7.2.2 Europe Dexlansoprazole Revenue by Application (2019-2030)
7.3 Europe Dexlansoprazole Market Size by Country
7.3.1 Europe Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Dexlansoprazole Sales by Country (2019-2030)
7.3.3 Europe Dexlansoprazole Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Dexlansoprazole Market Size
8.1.1 China Dexlansoprazole Sales (2019-2030)
8.1.2 China Dexlansoprazole Revenue (2019-2030)
8.2 China Dexlansoprazole Market Size by Application
8.2.1 China Dexlansoprazole Sales by Application (2019-2030)
8.2.2 China Dexlansoprazole Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dexlansoprazole Market Size by Type
9.1.1 Asia Dexlansoprazole Sales by Type (2019-2030)
9.1.2 Asia Dexlansoprazole Revenue by Type (2019-2030)
9.2 Asia Dexlansoprazole Market Size by Application
9.2.1 Asia Dexlansoprazole Sales by Application (2019-2030)
9.2.2 Asia Dexlansoprazole Revenue by Application (2019-2030)
9.3 Asia Dexlansoprazole Sales by Region
9.3.1 Asia Dexlansoprazole Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Dexlansoprazole Revenue by Region (2019-2030)
9.3.3 Asia Dexlansoprazole Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Dexlansoprazole Market Size by Type
10.1.1 Middle East, Africa and Latin America Dexlansoprazole Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Dexlansoprazole Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Dexlansoprazole Market Size by Application
10.2.1 Middle East, Africa and Latin America Dexlansoprazole Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Dexlansoprazole Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Dexlansoprazole Sales by Country
10.3.1 Middle East, Africa and Latin America Dexlansoprazole Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Dexlansoprazole Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Dexlansoprazole Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Takeda Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Cardinal Health
11.2.1 Cardinal Health Company Information
11.2.2 Cardinal Health Overview
11.2.3 Cardinal Health Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Cardinal Health Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cardinal Health Recent Developments
11.3 Suzhou Homesun Pharmaceutical
11.3.1 Suzhou Homesun Pharmaceutical Company Information
11.3.2 Suzhou Homesun Pharmaceutical Overview
11.3.3 Suzhou Homesun Pharmaceutical Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Suzhou Homesun Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Suzhou Homesun Pharmaceutical Recent Developments
11.4 Frontida
11.4.1 Frontida Company Information
11.4.2 Frontida Overview
11.4.3 Frontida Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Frontida Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Frontida Recent Developments
11.5 Zhendong Group
11.5.1 Zhendong Group Company Information
11.5.2 Zhendong Group Overview
11.5.3 Zhendong Group Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Zhendong Group Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhendong Group Recent Developments
11.6 Ouya Pharmaceutical
11.6.1 Ouya Pharmaceutical Company Information
11.6.2 Ouya Pharmaceutical Overview
11.6.3 Ouya Pharmaceutical Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Ouya Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ouya Pharmaceutical Recent Developments
11.7 Heron Pharmaceutical
11.7.1 Heron Pharmaceutical Company Information
11.7.2 Heron Pharmaceutical Overview
11.7.3 Heron Pharmaceutical Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Heron Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Heron Pharmaceutical Recent Developments
11.8 Sailong
11.8.1 Sailong Company Information
11.8.2 Sailong Overview
11.8.3 Sailong Dexlansoprazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Sailong Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sailong Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dexlansoprazole Industry Chain Analysis
12.2 Dexlansoprazole Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dexlansoprazole Production Mode & Process
12.4 Dexlansoprazole Sales and Marketing
12.4.1 Dexlansoprazole Sales Channels
12.4.2 Dexlansoprazole Distributors
12.5 Dexlansoprazole Customers
13 Market Dynamics
13.1 Dexlansoprazole Industry Trends
13.2 Dexlansoprazole Market Drivers
13.3 Dexlansoprazole Market Challenges
13.4 Dexlansoprazole Market Restraints
14 Key Findings in The Global Dexlansoprazole Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Takeda
Cardinal Health
SUZHOU HOMESUN PHARMACEUTICAL
Frontida
Zhendong Group
Ouya Pharmaceutical
Heron Pharmaceutical
Sailong
List of Tables
    Table 1. Global Dexlansoprazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 30 mg
    Table 3. Major Manufacturers of 60 mg
    Table 4. Global Dexlansoprazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Dexlansoprazole Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Dexlansoprazole Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Dexlansoprazole Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Dexlansoprazole Revenue Market Share by Region (2019-2024)
    Table 9. Global Dexlansoprazole Revenue Market Share by Region (2025-2030)
    Table 10. Global Dexlansoprazole Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Dexlansoprazole Sales by Region (2019-2024) & (K Units)
    Table 12. Global Dexlansoprazole Sales by Region (2025-2030) & (K Units)
    Table 13. Global Dexlansoprazole Sales Market Share by Region (2019-2024)
    Table 14. Global Dexlansoprazole Sales Market Share by Region (2025-2030)
    Table 15. Global Dexlansoprazole Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Dexlansoprazole Sales Share by Manufacturers (2019-2024)
    Table 17. Global Dexlansoprazole Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Dexlansoprazole Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Dexlansoprazole, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Dexlansoprazole Price by Manufacturers 2019-2024 (US$/Unit)
    Table 21. Global Dexlansoprazole Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Dexlansoprazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dexlansoprazole as of 2023)
    Table 23. Global Key Manufacturers of Dexlansoprazole, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Dexlansoprazole, Product Offered and Application
    Table 25. Global Key Manufacturers of Dexlansoprazole, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 28. Global Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 29. Global Dexlansoprazole Sales Share by Type (2019-2024)
    Table 30. Global Dexlansoprazole Sales Share by Type (2025-2030)
    Table 31. Global Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Dexlansoprazole Revenue Share by Type (2019-2024)
    Table 34. Global Dexlansoprazole Revenue Share by Type (2025-2030)
    Table 35. Dexlansoprazole Price by Type (2019-2024) & (US$/Unit)
    Table 36. Global Dexlansoprazole Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 37. Global Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 38. Global Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 39. Global Dexlansoprazole Sales Share by Application (2019-2024)
    Table 40. Global Dexlansoprazole Sales Share by Application (2025-2030)
    Table 41. Global Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Dexlansoprazole Revenue Share by Application (2019-2024)
    Table 44. Global Dexlansoprazole Revenue Share by Application (2025-2030)
    Table 45. Dexlansoprazole Price by Application (2019-2024) & (US$/Unit)
    Table 46. Global Dexlansoprazole Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 47. US & Canada Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Dexlansoprazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Dexlansoprazole Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Dexlansoprazole Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Dexlansoprazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Dexlansoprazole Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Dexlansoprazole Sales by Country (2025-2030) & (K Units)
    Table 73. China Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 74. China Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 75. China Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 78. China Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 79. China Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Dexlansoprazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Dexlansoprazole Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Dexlansoprazole Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Dexlansoprazole Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Dexlansoprazole Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Dexlansoprazole Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Dexlansoprazole Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Dexlansoprazole Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Dexlansoprazole Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Dexlansoprazole Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Dexlansoprazole Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Dexlansoprazole Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Dexlansoprazole Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Dexlansoprazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Dexlansoprazole Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Dexlansoprazole Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Dexlansoprazole Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Dexlansoprazole Sales by Country (2025-2030) & (K Units)
    Table 107. Takeda Company Information
    Table 108. Takeda Description and Major Businesses
    Table 109. Takeda Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Takeda Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Takeda Recent Developments
    Table 112. Cardinal Health Company Information
    Table 113. Cardinal Health Description and Major Businesses
    Table 114. Cardinal Health Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Cardinal Health Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Cardinal Health Recent Developments
    Table 117. Suzhou Homesun Pharmaceutical Company Information
    Table 118. Suzhou Homesun Pharmaceutical Description and Major Businesses
    Table 119. Suzhou Homesun Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Suzhou Homesun Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Suzhou Homesun Pharmaceutical Recent Developments
    Table 122. Frontida Company Information
    Table 123. Frontida Description and Major Businesses
    Table 124. Frontida Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Frontida Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Frontida Recent Developments
    Table 127. Zhendong Group Company Information
    Table 128. Zhendong Group Description and Major Businesses
    Table 129. Zhendong Group Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Zhendong Group Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Zhendong Group Recent Developments
    Table 132. Ouya Pharmaceutical Company Information
    Table 133. Ouya Pharmaceutical Description and Major Businesses
    Table 134. Ouya Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Ouya Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Ouya Pharmaceutical Recent Developments
    Table 137. Heron Pharmaceutical Company Information
    Table 138. Heron Pharmaceutical Description and Major Businesses
    Table 139. Heron Pharmaceutical Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. Heron Pharmaceutical Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Heron Pharmaceutical Recent Developments
    Table 142. Sailong Company Information
    Table 143. Sailong Description and Major Businesses
    Table 144. Sailong Dexlansoprazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Sailong Dexlansoprazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Sailong Recent Developments
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Dexlansoprazole Distributors List
    Table 150. Dexlansoprazole Customers List
    Table 151. Dexlansoprazole Market Trends
    Table 152. Dexlansoprazole Market Drivers
    Table 153. Dexlansoprazole Market Challenges
    Table 154. Dexlansoprazole Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dexlansoprazole Product Picture
    Figure 2. Global Dexlansoprazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Dexlansoprazole Market Share by Type in 2023 & 2030
    Figure 4. 30 mg Product Picture
    Figure 5. 60 mg Product Picture
    Figure 6. Global Dexlansoprazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Dexlansoprazole Market Share by Application in 2023 & 2030
    Figure 8. Gastroesophageal Reflux Disease
    Figure 9. Heal Erosive Esophagitis
    Figure 10. Dexlansoprazole Report Years Considered
    Figure 11. Global Dexlansoprazole Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Dexlansoprazole Revenue 2019-2030 (US$ Million)
    Figure 13. Global Dexlansoprazole Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Dexlansoprazole Revenue Market Share by Region (2019-2030)
    Figure 15. Global Dexlansoprazole Sales 2019-2030 ((K Units)
    Figure 16. Global Dexlansoprazole Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Dexlansoprazole Sales YoY (2019-2030) & (K Units)
    Figure 18. US & Canada Dexlansoprazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Dexlansoprazole Sales YoY (2019-2030) & (K Units)
    Figure 20. Europe Dexlansoprazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Dexlansoprazole Sales YoY (2019-2030) & (K Units)
    Figure 22. China Dexlansoprazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Dexlansoprazole Sales YoY (2019-2030) & (K Units)
    Figure 24. Asia (excluding China) Dexlansoprazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Dexlansoprazole Sales YoY (2019-2030) & (K Units)
    Figure 26. Middle East, Africa and Latin America Dexlansoprazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Dexlansoprazole Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Dexlansoprazole in the World: Market Share by Dexlansoprazole Revenue in 2023
    Figure 29. Global Dexlansoprazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 31. Global Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 32. Global Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 33. Global Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Dexlansoprazole Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Dexlansoprazole Sales Share by Country (2019-2030)
    Figure 40. U.S. Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 43. Europe Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 45. Europe Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Dexlansoprazole Revenue Share by Country (2019-2030)
    Figure 47. Europe Dexlansoprazole Sales Share by Country (2019-2030)
    Figure 48. Germany Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 49. France Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 53. China Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 54. China Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 55. China Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 56. China Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 58. Asia Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 60. Asia Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Dexlansoprazole Revenue Share by Region (2019-2030)
    Figure 62. Asia Dexlansoprazole Sales Share by Region (2019-2030)
    Figure 63. Japan Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 67. India Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Dexlansoprazole Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Dexlansoprazole Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Dexlansoprazole Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Dexlansoprazole Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Dexlansoprazole Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Dexlansoprazole Sales Share by Country (2019-2030)
    Figure 74. Brazil Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Dexlansoprazole Revenue (2019-2030) & (US$ Million)
    Figure 79. Dexlansoprazole Value Chain
    Figure 80. Dexlansoprazole Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Pantoprazole Market Research Report 2024
Dexlansoprazole Sustained Release Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pantoprazole Injection Market Research Report 2024
Global Pantoprazole Sodium Enteric Coated Tablets Market Research Report 2024
Global Omeprazole Capsule Market Research Report 2024
Global Lansoprazole Injection Market Research Report 2024
Global Oral Proton Pump Inhibitors PPIs Market Research Report 2024
Global Lansoprazole for Injection Market Research Report 2024
Global Rabeprazole Drug Market Insights Forecast to 2030
Pharmaceutical Grade Dexlansoprazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Omeprazole Injection Market Research Report 2024
Global Omeprazole Sodium for Injection Market Research Report 2024
Proton Pump Inhibitors Market
Global PPI Acid Suppressant Market Research Report 2024
Global Proton Pump Inhibitors for Gastric Acid Therapy Market Research Report 2025
Gastroesophageal Reflux Drugs Market
Global Prescription Proton Pump Inhibitor Market Research Report 2024
Global Proton Pump Inhibitors PPIs Market Research Report 2024
Global Gastric Antisecretory Drug Market Insights Forecast to 2030
Global Omeprazole API Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions